PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1139
https://www.valueinhealthjournal.com/article/S1098-3015(12)02852-5/fulltext
Title :
PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02852-5&doi=10.1016/j.jval.2012.08.1139
First page :
A398
Section Title :
Infection
Open access? :
No
Section Order :
640